Claim · claimSorter/cs-046

Cannabis has no accepted medical use, the Schedule I criterion is met

Education, not medical advice. Drafts and study material from an independent research library. Citations on this page were checked on Oct 13, 2026; claims in the body text and organizational sources are still under review. What was checked.

Cannabis has no accepted medical use, the Schedule I criterion is met

Refuted recorded as “Definitively Falsified” The Emperor Wears No Clothes

Prescription cannabidiol (purified CBD) is FDA-approved for Dravet syndrome and Lennox-Gastaut syndrome. Prescription synthetic THC (dronabinol) are Schedule III FDA-approved medications since 1985. 38 states have medical cannabis programs. The WHO ECDD (2019) explicitly recommended cannabis reclassification away from Schedule I, finding evidence of medical utility insufficient to justify current scheduling. The 'no accepted medical use' criterion has been factually inapplicable since at least 1985.

Links for this item

Posts: No post is recorded for this item yet.
Source page: The sources for this item on RN Collins Selected Work
Long-form: Medical Cannabis: From Herer's Argument to FDA-Approved Pharmaceuticals, the editorial draft this item belongs with
Gallery: See it in the gallery index
Project: About this library on RN Collins Selected Work
Corrections: Publication rules and the correction form

Drafts on the same book

The Twelve-Year Research Project Editorial draft
Hemp for Victory: The Film the Government Denied Editorial draft
The Billion Dollar Crop That Never Was Editorial draft
The Strain That Bears His Name Editorial draft
The Medical Argument: What Herer Knew Editorial draft
The Emperor's Legacy: What Changed Editorial draft
The Hemp War of 1812 Editorial draft
The Rescheduling: 2024-2026 and What It Actually Means Editorial draft
The Hemp Industry Herer Predicted: What Arrived Editorial draft
Reefer Madness and Racial Justice: The Unfinished Reckoning Editorial draft
Medical Cannabis: From Herer's Argument to FDA-Approved Pharmaceuticals Editorial draft
The $100,000 Challenge: Radical Transparency as Activism Editorial draft
Hemp for Victory: The Film That Was Hidden Editorial draft
The Timing of Nylon Editorial draft
Anderson's Lesson: Why the Title Is Right Editorial draft
Jack Herer: The Man Behind the Strain Editorial draft
Herer's Prohibition Theory: What Was Right and What Was Wrong Editorial draft
Passage: Hemp for Victory, 1942 Editorial draft
The Emperor's New Industry: Cannabis at $40 Billion Editorial draft
The Hemp Economy Herer Predicted: Industrial Cannabis in 2026 Editorial draft
What the Record Actually Shows Editorial draft

Reading list for this book

Reading list: The Emperor Wears No Clothes Reading list

NotebookLM packs on this book

What the Record Actually Shows NotebookLM source pack

Bridge pieces that use this book

The Aspirin Pill, the Decorticator, and the Double Loss Bridge piece

Science annotations on this book

Psilocybin, by increasing visual acuity at low doses, provided adaptive advantages to early hominids that... Science annotation

Then vs. Now comparisons on this book

Hemp's Industrial Potential: The Herer Claim Then vs. Now comparison
The DuPont-Hearst Conspiracy: Evidence Assessed Then vs. Now comparison
Cannabis Rescheduling: 2024-2026 Status Then vs. Now comparison
Hemp Prohibition's End: What Herer Lived to See Then vs. Now comparison
Cannabis and Racial Justice: Herer's Implicit Promise vs. the Industry Reality Then vs. Now comparison
The Endocannabinoid System Discovery: Herer Was Right About the Biology Then vs. Now comparison
The $40 Billion Cannabis Industry: Who Benefits? Then vs. Now comparison
The Agronomic Claim: Hemp vs. Cotton Then vs. Now comparison
The Federal Banking Problem: How Prohibition Persists Without Scheduling Then vs. Now comparison
The Medicinal Cannabis Science: From Historical Claims to Clinical Evidence Then vs. Now comparison

Other pages in this library that link here

The Politics of Plants Course module
The History of Prohibition: Primary Sources and Policy Teaching module